ArticleFrontiers in nutrition2026
Urinary bisphenol exposure and risk of type 1 diabetes and glycemic traits in Chinese children: a case-control study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bisphenol A (BPA) and its structural analogs, bisphenol F (BPF) and bisphenol S (BPS), are widely used in consumer products and increasingly detected in children. Although BPA has been linked to diabetes and impaired glucose metabolism in adults, evidence for BPF and BPS, particularly in the pediatric population, remains limited and inconsistent. This study examined the associations of individual and combined bisphenol exposures with type 1 diabetes mellitus (T1DM) risk and glucose homeostasis in children. Methods: We conducted a case-control study including 122 children with T1DM and 287 controls from Shenyang, China. For biomarker analysis, a subset of 110 participants (55 cases and 55 controls) was selected. Urinary bisphenol concentrations were measured using high-performance liquid chromatography-tandem mass spectrometry. Associations with T1DM risk and glycemic outcomes were evaluated using multivariable logistic and linear regression models. Bayesian kernel machine regression (BKMR) and Restricted cubic spline (RCS) analyses were further used to explore potential nonlinear relationships and interaction effects. Results: BPA was detected in all samples, with widespread exposure to BPF and BPS. Higher urinary BPA and BPF levels were significantly associated with increased odds of T1DM. BPS was not associated with T1DM status but was consistently linked to elevated fasting glucose ( Conclusion: Higher urinary concentrations of BPA and BPF were associated with increased odds of T1DM in children, while BPS was linked to markers of impaired glucose regulation. These findings suggest that BPA substitutes may not be biologically inert and could be relevant to metabolic health during childhood. Further prospective and mechanistic studies are needed to better understand the biological pathways underlying these associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.